Upgrade to SI Premium - Free Trial

Genelux (GNLX)

2.56 +0.06 (2.40%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Lucid Capital Markets Starts Genelux Corp. (GNLX) at Buy September 16, 2026 4:00 PM - StreetInsider Benchmark Reiterates Speculative Buy Rating on Genelux Corp. (GNLX) August 18, 2026 9:19 AM - StreetInsider Form 10-Q GENELUX Corp For: Jun 30 August 13, 2026 1:06 PM - SEC Filing Form 4 GENELUX Corp For: Aug 04 Filed by: Cappello Joseph August 4, 2026 8:20 PM - SEC Filing Form 4 GENELUX Corp For: Aug 04 Filed by: Yu Yong August 4, 2026 8:20 PM - SEC Filing Form 4 GENELUX Corp For: Aug 04 Filed by: Zindrick Thomas August 4, 2026 8:20 PM - SEC Filing Attovia Therapeutics names John Smither to board of directors July 15, 2026 8:30 AM - StreetInsider Attovia Therapeutics Appoints John W. Smither to Board of Directors July 15, 2026 8:30 AM - Globe NewsWire Full Article List